PCV47 ROSUVASTATIN 40MG VERSUS ATORVASTATIN 80MG IN HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLAEMIA- ECONOMIC ANALYSIS OF THE POLARIS STUDY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67458-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)67458-X/fulltext
Section Title :
Section Order :
23
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67458-X&doi=10.1016/S1098-3015(10)67458-X